NovoCure Ltd
NovoCure Ltd (NVCR) Option Chain
As of September 25, 2026, NovoCure Ltd is trading at $15.84, a -2.23% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 66.1%. IV Rank is 23%.
Read more
Tracking the NVCR option chain helps you see every strike and expiry on NovoCure Ltd in one view, so you can quickly identify the contracts that fit your thesis and your risk. NovoCure Ltd's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of NVCR options activity at a glance. Use our scanner to monitor the NVCR option chain in real time and filter for the NVCR options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For NVCR stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the NVCR option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where NVCR stock options are being actively traded and where they are not.
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer.
NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls NovoCure Ltd's full chain across every expiry, highlights the most liquid strikes, and lets you screen NVCR options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of NVCR stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV percentile51.98% Neutral
- Market cap (M$)1,845
- 52 weeks high-26.15%
- 52 weeks low61.30%
- Analyst recommendationBuy
1.86 - Target price$27.14
71.34% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-10-29
- P/E—
- Future P/E—
- EPS (ttm)-1.31
- EPS growth next 5 years32.69%
As of September 25, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 23.58 | 3 | 2 | 0.51 | 1.84 | 1.10 | 3.60 | 14.00 | -11.62 | 0.05 | 0.50 | 0.00 | 0.28 | 0 | 3 | 76.42 |
| 38.90 | 22 | 0 | 0.66 | 0.84 | 0.95 | 2.05 | 15.00 | -5.30 | 0.25 | 0.65 | 0.00 | 0.45 | 4 | 327 | 61.10 |
| 55.09 | 55 | 0 | 0.90 | 0.00 | 0.15 | 1.65 | 16.00 | +1.01 | 0.50 | 1.40 | 0.16 | 0.79 | 0 | 31 | 44.91 |
| 69.60 | 71 | 3 | 0.53 | 0.00 | 0.35 | 0.70 | 17.00 | +7.32 | 0.45 | 1.75 | 1.16 | -0.06 | 0 | 3 | 30.40 |
| 80.94 | 208 | 2 | 0.23 | 0.00 | 0.10 | 0.35 | 18.00 | +13.64 | 1.25 | 3.70 | 2.16 | 0.31 | 0 | 8 | 19.06 |
As of September 25, 2026
Scan the full option chain in one place
Browse the full NVCR option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→